INTRODUCTION {#s1}
============

Alzheimer's disease (AD) was a kind of diseases occurred in middle and old age \[[@R1]\], and was associated with some neurological symptoms and cognitive problems, including memory impairment, leading by neurodegeneration or synapse loss leading to and other cognitive problems \[[@R2]\]. Currently, there were a total of 6 million AD patients in China \[[@R3]\]. Clinically, late-onset AD (LOAD) is more common type of AD and the heritability for susceptibility to LOAD was predicted nearly 80% \[[@R4]\]. The etiology and pathogenesis for LOAD were still not clear, and study indicated that LOAD was influenced by interactions between genetic factors and environmental factors \[[@R5], [@R6]\]. So it is necessary to find and validate biomarkers for AD prevention, especially for LOAD.

Inflammation plays a main role in AD pathogenesis, and the inflammation irritants including damaged tissues and β-amyloid plaque \[[@R7]\]. Interleukin-16 (*IL-16*) is one type of gene, encoded pro- inflammatory cytokines \[[@R8]\]. Studies \[[@R9]\] indicated that *IL-16* levels increased in AD patients, confirming that *IL-16* may play an important role in the progression of AD \[[@R9]\]. The human *IL-16* gene could encode pleiotropic cytokine, which was a modulator of T cell activation \[[@R10]\]. However, to date, just two previous studies \[[@R11]- [@R12]\] were conducted on the association between *IL-16* gene single nucleotide polymorphisms (SNPs) and AD risk, but just one study focused on the correlation of rs4072111, rs1131445 polymorphisms and LOAD risk \[[@R11]\]. There was growing evidence demonstrating the association of adiponectin (*ANP*) gene SNPs with circulating adiponectin levels. rs266729and rs1501299 were two common SNPs. Some studies \[[@R13], [@R14]\] have reported the association between *ANP* gene polymorphisms and some metabolic diseases, such as insulin resistance and type 2 diabetes, but just one study \[[@R15]\] have focused on the association between *ANP* gene polymorphisms and LOAD.

In consideration of the limited number of study on association between *ANP* and *IL- 16* gene and LOAD, in this study, we aimed to investigate the impact of *ANP* and *IL- 16* gene SNPs, additional gene- gene interaction and haplotype combination on LOAD risk.

MATERIALS AND METHODS {#s2}
=====================

Participants {#s2_1}
------------

This is a case-control study. Participants are consecutively recruited between January 2009 and November 2014 from the Second Affiliated Hospital of Zhengzhou University. Clinical diagnosis of probable AD was made according to the revised criteria of National Institute of Neurological and Communicative Disorders and Stroke/ Alzheimer's Disease and Related Disorders Association (NINCDS/ ADRDA) \[[@R16]\], participants with advanced, severe, progressive, or unstable infectious, metabolic, immunologic, endocrinological, hepatic, hematological, pulmonary, cardiovascular, gastrointestinal, and/or urological diseases are excluded (Figure [1](#F1){ref-type="fig"}). At last, a total of 430 LOAD patients are included in the study, controls are those who are free of AD and matched by sex, age and ethnic background, and control participants with family history of AD are excluded. The selection and exclusion details could be found in our previous study \[[@R17]\].

![A flowchart on study population selection and exclusion](oncotarget-08-79157-g001){#F1}

Data collection {#s2_2}
---------------

Data on demographic information, mini-mental state examination (MMSE), educational year, lifestyle risk factors, smoking and drinking status, prevalence of stroke, prevalence of diabetes and family history of AD for all participants are obtained using a questionnaire administered by trained staffs. Body weight, height and waist circumference (WC) are measured, and body mass index (BMI) are calculated. Blood samples are collected in the morning after at least 8 hours of fasting. All plasma and serum samples are frozen at -80°C until laboratory testing. Plasma glucose is measured using an oxidase enzymatic method. The concentrations of HDL cholesterol and triglycerides are assessed enzymatically using an automatic biochemistry analyzer (Hitachi Inc., Tokyo, Japan) and commercial reagents. Plasma ANP concentration was measured using Adiponectin ELISA kit (Shanghai Huzhen Biological Technology Co., Ltd. China).

Genomic DNA extraction and genotyping {#s2_3}
-------------------------------------

SNPs within the *ANP* and *IL-16* gene are selected according to the following methods: 1) SNPs, which have been reported associations with AD and were not been well studied; 2) SNPs, the minor allele frequency (MAF) of which were more than 5%. At last, two SNPs of *ANP* gene and two SNPs of *IL- 16* gene are selected for genotyping in the study: rs266729, rs4072111, rs1501299 and rs1131445. Genomic DNA is extracted from EDTA-treated whole blood, using the DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Genotyping of these SNPs were performed using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. PCR primer sequences for each polymorphism are shown in Table [1](#T1){ref-type="table"}. The PCR reactions were carried out in a final volume of 25 μl containing: 10 × PCR buffer, 4.5 mMMgCl2 (Roche, Germany), 0.4 mM of each dNTP (Fermentas, Germany), 10 pmol of each primer, 30 ng template DNA, 1 U Taq DNA polymerase (Roche, Germany) and sterile distilled water up to 25 μl. Amplification conditions started with an initial denaturation step of 5 min at 94 °C, followed by 35 cycles of 40 s denaturation (94 °C), 30 s annealing (56 °C) and 40 s extension (72 °C), ended by a final extension for 5min (72 °C).

###### Description and primer sequences for 4 SNPs used for PCR analysis

  ----------------------------------------------------------------------------------------------------------------------------------------------
  SNP ID          Chromosome    Functional Consequence                         Major/ minor alleles   Probe sequence
  --------------- ------------- ---------------------------------------------- ---------------------- ------------------------------------------
  *ANP* gene                                                                                          

  rs266729        3:186841685   Upstream variant 2KB                           C/ G                   Forward: 5′- ACTTGCCCTGCCTCTGTCTG-3′\
                                                                                                      Reverse: 5′-CCTGGAGAACTGGAAGCTG-3′

  rs1501299       3:186853334   Intron variant                                 G/ T                   Forward: 5′- GGCTCAGGATGCTGTTGCTG-3′\
                                                                                                      Reverse: 5′-AGGGATGAGGGTGAAGATGGGA-3′

  *IL- 16* gene                                                                                       

  rs1131445       15:81309441   Downstream variant 500B, utr variant 3 prime   T/ C                   Forward: 5′-GAGATCATTCACTCATACATCTGG-3′\
                                                                                                      Reverse: 5′-TCATATACACGCTGGTTCCTTCTG-3′

  rs4072111       15:81285798   Missense, nc transcript variant                C/ T                   Forward: 5′-CACTGTGATCCCGGTCCAGTC-3′\
                                                                                                      Reverse: 5′-TTCAGGTACAAACCCAGCCAGC-3′
  ----------------------------------------------------------------------------------------------------------------------------------------------

Statistical analysis {#s2_4}
--------------------

The means and standard deviations were calculated for normally distributed continuous variables, and percentages were calculated for categorical variables. The categorical data were analyzed using χ^2^ test, and continuous variables were analyzed using Student's t test. Hardy-Weinberg equilibrium (HWE), haplotype analysis and pairwise linkage disequilibrium (LD) analysis were investigated by using SNPStats (available online at <http://bioinfo.iconcologia.net/SNPstats>). Logistic regression was performed to investigate association between SNP and LOAD by dominant and co- dominant models. All reported *P*-values were two-tailed, and those less than 0.05 were considered statistically significant.

Generalized multifactor dimensionality reduction (GMDR) \[[@R18]\] was used to analysis the interaction among 4 SNPs, cross-validation consistency, the testing balanced accuracy, and the sign test, to assess each selected interaction were calculated. Permutation testing is also conducted to gain empirical P values of prediction accuracy as a benchmark based on 10,000 shuffles. The cross-validation consistency score is a measure of the degree of consistency with which the selected interaction is identified as the best model among all possibilities considered. Testing-balanced accuracy is a measure of the degree to which the interaction accurately predicts case-control status, and yields a score between 0.50 (indicating that the model predicts no better than chance) and 1.00 (indicating perfect prediction). Finally, the sign test, or permutation test (providing empirical *P*-values), for prediction accuracy can be used to measure the significance of an identified model.

RESULTS {#s3}
=======

A total of 880 participants (514 males, 366 females) were selected, including 430 LOAD patients and 450 control subjects. The mean age of all participants was 81.7 ± 15.9 years old. The cases have the higher alcohol- drinking rate than controls. The means of FPG and TG were significantly higher in cases and controls, but the mean of HDL was lower in cases and controls. The mean of *ANP* concentrations was higher in controls than that in cases (Table [2](#T2){ref-type="table"}).

###### General characteristics of 880 study participants in case and control group

  -------------------------------------------------------------------------
  Variables                      Case group\   Normal group\   *p*-values
                                 (*n*=430)     (*n*=450)       
  ------------------------------ ------------- --------------- ------------
  Age (year)                     81.4±16.1     82.3±15.7       0.401

  Males, *N* (%)                 246 (57.2)    268(59.6)       0.480

  Smoke, *N* (%)                 151 (35.1)    145(32.2)       0.364

  Alcohol consumption, *N* (%)   188 (43.7)    160 (35.6)      0.013

  WC (cm)                        89.2±19.8     87.7±19.4       0.257

  BMI (kg/m^2^)                  25.1±8.9      24.8±9.1        0.621

  FPG (mmol/L)                   5.8±1.6       5.5±1.9         0.012

  TG (mmol/L)                    1.4±0.8       1.3± 0.7        0.048

  TC (mmol/L)                    4.6±0.8       4.5±0.9         0.082

  HDL (mmol/L)                   1.21±0.65     1.34±0.63       0.002

  Stroke                         16 (3.72)     20 (4.44)       0.255

  MMSE (scores)                  15.16±5.51    29.12±4.97      \<0.001

  Diabetes                       36 (8.37)     43(9.56)        0.539

  Educational year               7.5±3.12      7.8±3.31        0.167

  ANP (mg/L)                     3.65±1.06     5.62±1.23       \<0.001
  -------------------------------------------------------------------------

Note: Means± standard deviation for age, WC, BMI, FPG, TC, TG, HDL-C and ANP; Abbreviations:TC, total cholesterol; HDL, high density lipoprotein; FPG, fast plasma glucose; TG, triglyceride; WC, waist circumference; BMI, body mass index; MMSE, mini-mental state examination; ANP, Adiponectin. Those *P-* values less than 0.05 were considered statistically significant.

The frequencies for rs266729- G allele and rs1501299- T allele in *ANP* gene were significantly higher in LOAD cases than that in control group (30.4% *vs*19.4%, 32.6% *vs*19.9%), and T allele of rs4072111 in *IL- 16* was significantly lower in LOAD cases than that in control group (19.9 % *vs*29.9%). Logistic regression analysis showed that LOAD risk was significantly higher in carriers with rs266729- G allele than those with CC genotype (CG+ GG *versus* CC), adjusted OR (95%CI) = 1.61 (1.26-1.96), and higher in carriers with rs1501299- T allele than those with GG genotype (GT+ TT *versus* GG), adjusted OR (95%CI) = 1.62 (1.32-2.12). In addition, we also found LOAD risk was also significantly lower in carriers with rs4072111- T allele than those with CC genotype (CT+ TT *versus* CC), adjusted OR (95%CI) = 0.65 (0.44-0.93). (Table [3](#T3){ref-type="table"})

###### Genotype and allele frequencies of 4 SNPs between case and control group

  Gene/ SNP       Genotypes and Alleles   Frequencies N (%)   OR(95%CI)\*   *P*- values       *P*- values for HWE test in controls   
  --------------- ----------------------- ------------------- ------------- ----------------- -------------------------------------- -------
  *ANP* gene                                                                                                                         
  rs266729        Codominant                                                                                                         
                  CC                      213(49.5)           294 (65.3)    1.00                                                     0.550
                  CG                      173(40.2)           137 (30.5)    1.53(1.22-1.85)   \<0.001                                
                  GG                      44(10.3)            19 (4.2)      2.10(1.43-2.94)   \<0.001                                
                  Dominant                                                                                                           
                  CC                      213(49.5)           294 (65.3)    1.00                                                     
                  CG +GG                  217(50.5)           156 (34.7)    1.61(1.26-1.96)   \<0.001                                
                  Allele, G (%)           261(30.4)           175(19.4)                                                              
  rs1501299       Codominant                                                                                                         
                  GG                      201(46.7)           289(64.2)     1.00                                                     0.953
                  GT                      178(41.4)           143(31.8)     1.57(1.25-1.98)   \<0.001                                
                  TT                      51(11.9)            18(4.0)       2.05(1.51-2.72)   \<0.001                                
                  Dominant                                                                                                           
                  GG                      201(46.7)           289(64.2)     1.00                                                     
                  GT+TT                   229(53.3)           161(35.8)     1.62(1.32-2.12)   \<0.001                                
                  Allele, T (%)           280(32.6)           179(19.9)                                                              
  *IL- 16* gene                                                                                                                      
  rs1131445       Codominant                                                                                                         
                  TT                      251(58.4)           240(53.3)     1.00                                                     0.898
                  TC                      156(36.3)           178(39.6)     0.75(0.47-1.09)   0.107                                  
                  CC                      23(5.3)             32(7.1)       0.67(0.32-1.03)   0.092                                  
                  Dominant                                                                                                           
                  TT                      251(58.4)           240(53.3)     1.00                                                     
                  TC+CC                   179(41.6)           210(46.7)     0.73(0.44-1.08)   0.103                                  
                  Allele, C (%)           202(23.5)           242(26.9)                                                              
  rs4072111       Codominant                                                                                                         
                  CC                      281(65.3)           229(50.9)     1.00                                                     0.079
                  CT                      127(29.5)           173(38.4)     0.68(0.47-0.93)   0.0012                                 
                  TT                      22(5.2)             48(10.7)      0.56(0.26-0.91)   \<0.001                                
                  Dominant                                                                                                           
                  CC                      281(65.3)           229(50.9)                                                              
                  CT+TT                   149(34.7)           221(49.1)     0.65(0.44-0.93)   0.001                                  
                  Allele, T (%)           171(19.9)           269(29.9)                                                              

\*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes. Those *P-* values less than 0.05 were considered statistically significant.

We investigate the impact of the interaction among 4 SNPs within *ANP* and *IL- 16* gene on LOAD risk by using GMDR analysis. We found a significant two-locus model (*p* = 0.0100) involving rs266729 and rs4072111, and the cross-validation consistency of this model was 10/ 10, and the testing accuracy was 60.72%. Participants with CG or GG of rs266729 and CC of rs4072111 genotype have the highest LOAD risk, compared to participants with CC of rs266729 and CT or TT of rs4072111 genotype, OR (95%CI) = 2.62(1.64 -3.58), after covariates adjustment for alcohol consumption status, FPG, TG and HDL (Table [5](#T5){ref-type="table"}).

###### Best gene--gene interaction models, as identified by GMDR

  Locus no.   Best combination                         Cross-validation consistency   Testing accuracy   *p*-values \*
  ----------- ---------------------------------------- ------------------------------ ------------------ ---------------
  2           rs266729 rs4072111                       10/10                          0.6072             0.0100
  3           rs266729 rs4072111 rs1501299             9/10                           0.5590             0.0547
  4           rs266729 rs4072111 rs1501299 rs1131445   8/10                           0.5399             0.3770

\*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes. Those *P-* values less than 0.05 were considered statistically significant.

###### Interaction analysis for rs266729 and rs4072111 by using logistic regression

  rs266729   rs4072111   OR (95% CI)\*       *P*-values
  ---------- ----------- ------------------- ------------
  CC         CT or TT    1.00                \-
  CG or GG   CT or TT    1.18 (1.04 -1.87)   0.026
  CC         CC          1.83 (1.48-2.69)    \<0.001
  CG or GG   CC          2.62 (1.64 -3.58)   \<0.001

\*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes. Those *P-* values less than 0.05 were considered statistically significant.

Pairwise LD analysis between SNPs was measured, and D′ value between rs266729 and rs1501299 was 0.826, D′ value between rs1131445 and rs4072111 was 0.861. Haplotype containing the rs266729- G and rs1501299- T alleles were associated with a statistically increased LOAD risk (OR = 1.83, 95%CI = 1.32- 2.43, *P* \< 0.001) (Table [6](#T6){ref-type="table"}), and haplotype containing the rs1131445- C and rs4072111- T alleles were associated with a statistically decreased LOAD risk (OR = 0.53, 95%CI = 0.18- 0.95, *P* = 0.012) (Table [7](#T7){ref-type="table"}).

###### Haplotype analysis on association between *ANP* gene and LOAD risk

  Haplotypes   rs266729   rs1501299   Frequencies   OR(95%CI)   *p*-values\*          
  ------------ ---------- ----------- ------------- ----------- --------------------- ---------
  H1           C          G           0.4601        0.5567      1.00                  \--
  **H2**       **G**      **G**       0.2267        0.2131      1.13 (0.81-- 1.62)    0.592
  H3           C          T           0.2135        0.1821      1.27 (0.90 - 1.74)    0.602
  H4           G          T           0.0997        0.0481      1.83 (1.32 -- 2.43)   \<0.001

\*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes.

Those *P-* values less than 0.05 were considered statistically significant.

###### Haplotype analysis on association between *IL- 16* and LOAD risk

  Haplotypes   rs1131445   rs4072111   Frequencies   OR(95%CI)   *p*-values\*          
  ------------ ----------- ----------- ------------- ----------- --------------------- -------
  H1           **T**       C           0.5103        0.4367      1.00                  \--
  H2           **C**       C           0.2624        0.2805      0.67 (0.35 -- 1.02)   0.091
  H3           **T**       T           0.1926        0.2101      0.72 (0.49 - 1.06)    0.328
  H4           **C**       T           0.0347        0.0727      0.53 (0.18 -- 0.95)   0.012

\*Adjusted for gender, age, smoking and alcohol status, BMI, WC, FPG, TC, TG, HDL, educational year, prevalence of stroke, prevalence of diabetes. Those *P-* values less than 0.05 were considered statistically significant.

DISCUSSION {#s4}
==========

In the current study, we found that higher LOAD risks were significantly associated with rs266729- G allele and rs1501299- T allele than those with GG genotype. In addition, we also found that lower LOAD risk was associated with rs4072111- T allele. To date, the relationship between *ANP* gene polymorphism and LOAD risk was not well known, Li et al \[[@R15]\] firstly indicated that the susceptibility to LOAD was higher in carriers of the rs266729- G allele or carriers of the rs1501299- T allele. Previously, studies have involved in *ANP* gene polymorphisms and the others phenotypes. Studies have suggested that higher circulating *ANP* concentration was associated with lower AD risk \[[@R19], [@R20]\]. Recently, Tong et al \[[@R21]\] found that CC allele was associated with lower serum ANP concentrations, and GG genotype was associated with increased metabolic syndrome and insulin resistance risk \[[@R13], [@R22]\]. In terms of the correlation of LOAD risk with rs1501299, recent studies \[[@R14], [@R23], [@R24]\] also found that serum ANP concentrations were lower in carriers of TT allele.

In recent two studies \[[@R11], [@R12]\], *IL- 16* gene was associated with LOAD risk. Khoshbakht et al \[[@R12]\] suggested that rs11556218 and rs4778889 polymorphisms within *IL- 16* gene have a protective role in the development of sporadic AD in Iranian population. In the other study conducted by Anvar et al \[[@R11]\] suggested that the rs4072111 variation was associated with increased AD susceptibility in an Iranian population. Rosa et al \[[@R9]\] confirmed that *IL-16* proteins may play an important role in progression of neurodegenerative disorders. Regarding to the relationship between rs4072111, rs1131445 and LOAD, the current study was the second study that concluded a positive association between the *IL16*- rs4072111 polymorphism and LOAD risk. However several studies \[[@R25]- [@R27]\] have reported the association between *IL- 16* gene polymorphism and risk of coronary heart disease (CHD) risk in different population. This relation many be another underlying mechanism for LOAD risk reduction by *IL- 16* polymorphism, because CHD was also associated with AD risk factors, including obesity, metabolic syndrome, and insulin resistance.

In this study, LOAD risk is influenced by both *ANP* and *IL- 16* gene, so it is interesting to investigate the impact of gene- gene interaction between the two genes on LOAD risk. In this study, GMDR model was used for interaction detection, because there were no dimensional constraints in this model. We found a significant gene- gene interaction between rs266729 and rs4072111. To our knowledge this is the first study for investigating impact of interaction between ANP and *IL- 16* gene on LOAD risk in Chinese population. Previously, just two studies \[[@R17], [@R28]\] focused on the impact of gene- gene interaction on AD risk, which was conducted between *APOE* and *PPAR -γ* gene for Spain population and *CYP2J2* and *PPAR -γ* gene for Chinese Han population. The results of this study suggest that *ANP* genetic variants may modify the influence of *IL- 16* gene on AD risk. The underlying mechanisms for this interaction may due to that both SNP were associated with AD risk factors. We also conducted haplotype analysis in *ANP* gene and *IL- 16* gene respectively. We found that haplotype containing the rs266729- G and rs1501299- T alleles in *ANP* gene were associated with a statistically increased LOAD risk, and haplotype containing the rs1131445- C and rs4072111- T alleles in *IL- 16* gene were associated with a statistically decreased LOAD risk

The current study also has some limitations. Firstly, limited number of SNP in *ANP* and *IL- 16* gene are included in current study, and in the future, more SNPs should be included in analysis. Secondly, gene- environment interaction should be investigated in the future studies, such as lifestyle, diet factors and so on. Thirdly, more detailed analysis should be conducted in other populations, for example, the gender and race difference of this relationship.

In conclusion, the results of current study indicated that LOAD risks are significantly higher in carriers with rs266729- G allele than those with CC genotype, and higher in carriers with rs1501299- T allele than those with GG genotype, and lower in carriers with rs4072111- T allele than those with CC genotype. We also found a significant gene- gene interaction between rs266729 and rs4072111, participants with CG or GG of rs266729 and CC of rs4072111 genotype have the highest LOAD risk, compared to participants with CC of rs266729 and CT or TT of rs4072111 genotype. And haplotype containing the rs266729- G and rs1501299- T alleles in *ANP* gene were associated with a statistically increased LOAD risk, and haplotype containing the rs1131445- C and rs4072111- T alleles in *IL- 16* gene were associated with a statistically decreased LOAD risk
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